Roland Buhl Selected Research

Muscarinic Antagonists

5/2022	Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
11/2020	Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management.
10/2020	Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials.
1/2020	Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies.
1/2020	Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD.
1/2020	A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland Buhl Research Topics

Disease

76	Asthma (Bronchial Asthma) 06/2022 - 08/2003
52	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2002
18	Inflammation (Inflammations) 01/2020 - 06/2003
11	Neoplasms (Cancer) 11/2019 - 01/2003
9	Dyspnea (Shortness of Breath) 01/2020 - 01/2002
6	Respiratory Hypersensitivity 01/2020 - 08/2005
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2009 - 01/2007
4	Symptom Flare Up 01/2022 - 01/2022
4	COVID-19 08/2021 - 01/2020
4	Hypersensitivity (Allergy) 01/2020 - 01/2005
4	Lung Neoplasms (Lung Cancer) 07/2018 - 05/2008
4	Lung Diseases (Lung Disease) 01/2017 - 07/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 01/2005
3	Eosinophilia 01/2020 - 02/2013
3	Pneumonia (Pneumonitis) 01/2019 - 01/2005
3	Allergic Rhinitis 01/2014 - 09/2003
2	Airway Obstruction (Choking) 02/2022 - 01/2017
2	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2020
2	Infections 01/2020 - 01/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 01/2014
2	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2017 - 01/2012
2	Emphysema 07/2014 - 02/2014
2	Fibrosis (Cirrhosis) 07/2014 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 02/2014 - 05/2010
2	Adenocarcinoma 01/2007 - 09/2004
1	Eczema 01/2021
1	Metaplasia 01/2020
1	Rhinosinusitis 01/2020
1	Urticaria (Hives) 01/2020

Drug/Important Bio-Agent (IBA)

42	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 08/2003
27	Tiotropium Bromide (Spiriva)FDA Link 11/2020 - 01/2012
24	Bronchodilator Agents (Bronchodilators)IBA 02/2022 - 01/2002
20	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 08/2003
19	Muscarinic AntagonistsIBA 05/2022 - 12/2010
16	tiotropium-olodaterolIBA 12/2020 - 06/2015
13	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2003
12	indacaterolIBA 06/2022 - 06/2010
12	Budesonide (Pulmicort)FDA LinkGeneric 08/2021 - 08/2003
12	AllergensIBA 01/2020 - 09/2003
11	GoldIBA 06/2021 - 01/2007
11	olodaterolIBA 01/2020 - 04/2015
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2022 - 12/2005
10	Immunoglobulin E (IgE)IBA 02/2022 - 01/2005
10	Monoclonal AntibodiesIBA 01/2021 - 01/2007
9	Omalizumab (Xolair)FDA Link 01/2019 - 01/2005
8	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 06/2022 - 12/2010
7	mepolizumabIBA 04/2022 - 08/2012
6	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 01/2002
5	Biological ProductsIBA 01/2022 - 12/2017
5	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 05/2008
5	anti-IgE antibodiesIBA 01/2021 - 01/2005
5	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 08/2003
5	AntibodiesIBA 01/2020 - 01/2005
5	Formoterol Fumarate Drug Combination Budesonide FDA Link 02/2012 - 08/2003
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2022
4	AntigensIBA 01/2019 - 12/2003
4	Pharmaceutical PreparationsIBA 01/2015 - 08/2003
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 06/2022 - 01/2020
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021 - 01/2004
3	SteroidsIBA 01/2020 - 05/2008
3	Interleukin-13IBA 01/2020 - 05/2010
3	Interleukin-5 (Interleukin 5)IBA 01/2020 - 05/2015
3	Triggering Receptor Expressed on Myeloid Cells-1IBA 07/2018 - 01/2007
3	Methacholine Chloride (Methacholine)FDA Link 05/2015 - 09/2003
3	indacaterol-glycopyrronium combinationIBA 04/2015 - 12/2010
2	Enterotoxins (Enterotoxin)IBA 01/2020 - 08/2012
2	reslizumabIBA 01/2019 - 07/2017
2	Therapeutic UsesIBA 01/2017 - 01/2014
2	AutoantibodiesIBA 11/2015 - 12/2003
2	InterleukinsIBA 08/2012 - 04/2003
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2012 - 05/2008
2	ciclesonide FDA Link 01/2012 - 01/2006
2	prednylidene (Pred)IBA 12/2011 - 02/2011
2	Interleukin-8 (Interleukin 8)IBA 05/2010 - 04/2003
2	ParaffinIBA 01/2009 - 01/2007
2	Adenosine Monophosphate (AMP)IBA 08/2005 - 09/2003
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2005 - 01/2004
2	Oxidants (Oxidizing Agents)IBA 12/2004 - 10/2004
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 10/2004 - 04/2004
2	Stem Cell FactorIBA 09/2004 - 01/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2004 - 01/2003
2	LigandsIBA 09/2004 - 01/2003
2	Glutathione (Reduced Glutathione)IBA 07/2004 - 04/2004
2	Prednisolone (Predate)FDA LinkGeneric 01/2004 - 01/2004
1	Acetates (Acetic Acid Esters)FDA Link 10/2021
1	PlatinumIBA 10/2021
1	GlucocorticoidsIBA 01/2021
1	benralizumabIBA 01/2021
1	PeriostinIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020

Therapy/Procedure

48	Therapeutics 05/2022 - 01/2004
8	Nebulizers and Vaporizers (Inhaler) 01/2022 - 08/2003
5	Biological Therapy 01/2022 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2015 - 01/2003
2	Ambulatory Care (Outpatient Care) 11/2019 - 01/2016
2	Lung Transplantation 08/2016 - 02/2014
1	Precision Medicine 01/2021